Direct-Acting Antivirals for Chronic Hepatitis C: Can Drug Properties Signal Potential for Liver Injury?

Gastroenterology. 2017 May;152(6):1270-1274. doi: 10.1053/j.gastro.2017.03.012. Epub 2017 Mar 19.

Authors

Poonam Mishra¹, Minjun Chen²

Affiliations

¹ US Food and Drug Administration, Silver Spring, Maryland.
² US Food and Drug Administration, Jefferson, Arkansas. Electronic address: minjun.chen@fda.hhs.gov.

PMID: 28327365
DOI: 10.1053/j.gastro.2017.03.012

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / adverse effects*
Antiviral Agents / chemistry
Chemical and Drug Induced Liver Injury / diagnosis
Chemical and Drug Induced Liver Injury / etiology*
Hepatitis C, Chronic / diagnosis
Hepatitis C, Chronic / drug therapy*
Humans
Models, Statistical
Risk Assessment
Risk Factors

Substances

Antiviral Agents